Your search returned 8 results.

Results
	1.	Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Letter]. [electronic resource] by Orsatti, Leticia Fortea, Josep Quaresma, Manuel Producer: 20190624 In: Drug design, development and therapy vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis. [electronic resource] by Roger, Albert Fortea, Josep Mora, Sheila Artés, Maite Producer: 20121002 In: Expert review of pharmacoeconomics & outcomes research vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries. [electronic resource] by Andresen, Viola Whorwell, Peter Fortea, Josep Auzière, Sébastien Producer: 20150205 In: United European gastroenterology journal vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom. [electronic resource] by Dibonaventura, Marco Dacosta Prior, Mercedes Prieto, Pablo Fortea, Josep Producer: 20121120 In: Clinical and experimental gastroenterology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom. [electronic resource] by Raber, Anna Heras, Joan Costa, Joan Fortea, Josep Cobos, Albert Producer: 20110714 In: Therapeutics and clinical risk management vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea. [electronic resource] by Letzel, Heinz Mégard, Yves Lamarca, Rosa Raber, Anna Fortea, Josep Producer: 20070220 In: European journal of obstetrics, gynecology, and reproductive biology vol. 129 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults. [electronic resource] by Antonijoan, Rosa M García-Gea, Consuelo Puntes, Montserrat Valle, Marta Esbri, Ramon Fortea, Josep Barbanoj, Manuel J Producer: 20070828 In: Clinical drug investigation vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. [electronic resource] by Antonijoan, Rosa García-Gea, Consuelo Puntes, Montserrat Pérez, Joselin Esbrí, Ramón Serra, Cristina Fortea, Josep Barbanoj, Manuel J Producer: 20070905 In: Clinical therapeutics vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)